Top 10 Largest Hospice Providers of 2020

Despite facing forceful pandemic-related headwinds from COVID-19, mergers and acquisitions and organic growth are fueling market share growth among the organizations listed in the LexisNexis 2020 Top Hospice Providers report. VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHE), led the charge as the largest hospice provider in the United States last year, with 4.42% […]

Amedisys Closes $235 Million AseraCare Deal

Amedisys, Inc. (NASDAQ:AMED) has completed its acquisition of Homecare Preferred Choice, Inc., doing business as AseraCare Hospice. Amedisys acquired 100% ownership of AseraCare for a cash price of $235 million.  AseraCare operates 44 hospice locations throughout 14 states with an average daily census that exceeds 2,100. The company generates $117 million in revenue annually. With […]

Amedisys Poised for COVID-19 Recovery, Further Hospice Growth

The Amedisys, Inc. (NASDAQ: AMED) hospice segment saw a drop in referrals and rising costs stemming from the COVID-19 pandemic during the first quarter of this year. Though the outbreak creates industry-wide uncertainty about the future, demographic tailwinds, de novo activity and acquisitions show promise for a strong recovery, including the company’s $235 million purchase […]

Amedisys to Acquire AseraCare Hospice for $235 Million

Hospice and home health provider Amedisys, Inc. (NASDAQ:AMED) has entered into a definitive agreement to purchase Texas-based AseraCare Hospice for a cash purchase price of $235 million. Amedisys has had its eye on AseraCare for a number of years. “In 2016 we actually approached the AseraCare, and at that time they weren’t for sale. We’ve […]

Amedisys to Purchase Asana Hospice

Amedisys, Inc. (NASDAQ: AMED) has entered into a definitive agreement to purchase Asana Hospice for an undisclosed amount. The transaction is expected to close Jan. 1, 2020. Amedisys has been doubling down on hospice acquisitions this year, building up its hospice footprint as the company braces for disruption to its home health care business stemming […]

The Top 10 Largest Hospice Providers of 2019

Though the hospice space remains fragmented, mergers and acquisitions are driving up market share, particularly for large providers. Along with service diversification and application of emerging technologies, M&A is helping to drive growth among the organizations named in LexisNexis Top 100 Hospices of 2019. With 4.5% of market share, VITAS Healthcare, a subsidiary of Chemed […]

Acquisitions Spur Amedisys’ Hospice Growth

Amedisys Inc. (NASDAQ: AMED) is continuing to use acquisitions to build up its hospice footprint as the company braces for disruption to its home health care business stemming from the forthcoming transition to the patient driven groupings model (PDGM).  In the third quarter of 2019 Amedisys hospice segment revenue rose to $162 million, a 57% […]

Hospice M&A Market Going Strong in 2019

All signs point to a strong showing for hospice mergers and acquisitions through the year and into 2020 as companies and investors shy away from home health in anticipation of potential fallout from the forthcoming patient-driven groupings (PDGM) model. Eight hospice acquisitions took place during the first quarter of 2019, up from seven transactions during […]

Amedisys to ‘Feed the Beast’ for Hospice Segment Growth

Amedisys Inc., (NASDAQ: AMED),the third largest provider of hospice and home health in the United States, is prioritizing expansion of its hospice footprint through acquisitions and de novo activity, as the company cools down its home health care acquisition efforts due to uncertainties regarding the patient driven groupings model (PDGM). A focus on hospice growth […]

Rising Admissions Drive Amedisys Q1 Hospice Results

Rising hospice admission numbers led Baton Rouge, La.-based Amedisys Inc. (NASDAQ: AMED) to robust earnings in the first quarter of 2019. The rise in admissions includes both same-store and those associated with acquisitions. Same-store hospice admissions for Q1 2019 rose 5% to 9,711 patients, up from 6,933 in the first quarter of 2018. Average daily […]